Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivoGuoshun Luo, Hua Xiang, Xin Lin et al.|Acta Pharmaceutica Sinica B|2020Cited by 77
Engineered platelets as targeted protein degraders and application to breast cancer modelsYu Chen, Quanyin Hu|Nature Biotechnology|2024Cited by 28